Evidence map›Paper›PMID 30128315›Full record

ArticleAnnals of clinical and translational neurology2018

7 Tesla MRI of Balo's concentric sclerosis versus multiple sclerosis lesions.

Janina R Behrens, Julia Wanner, Joseph Kuchling, Lennard Ostendorf, Lutz Harms, Klemens Ruprecht, Thoralf Niendorf, Sven Jarius, Brigitte Wildemann, René M Gieß and 5 more

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Hypoxia in multiple sclerosis.Redox biology · 2025
    Review
  3. Article
  4. Knowledge and awareness on Balo's disease among dental students: A survey.Journal of advanced pharmaceutical technology & research · 2022
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Janina R BehrensCharité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health NeuroCure Cluster of Excellence NeuroCure Clinical Research Center Berlin Germany.
Julia WannerCharité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health NeuroCure Cluster of Excellence NeuroCure Clinical Research Center Berlin Germany.
Joseph KuchlingCharité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health NeuroCure Cluster of Excellence NeuroCure Clinical Research Center Berlin Germany.
Lennard OstendorfCharité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health NeuroCure Cluster of Excellence NeuroCure Clinical Research Center Berlin Germany.
Lutz HarmsCharité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin Department of Neurology Humboldt-Universität zu Berlin, and Berlin Institute of Health Berlin Germany.
Klemens RuprechtCharité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health NeuroCure Cluster of Excellence NeuroCure Clinical Research Center Berlin Germany.
Thoralf NiendorfBerlin Ultrahigh Field Facility Max Delbrück Center for Molecular Medicine in the Helmholtz Association Berlin Germany.
Sven JariusMolecular Neuroimmunology Group Department of Neurology University of Heidelberg Heidelberg Germany.
Brigitte WildemannMolecular Neuroimmunology Group Department of Neurology University of Heidelberg Heidelberg Germany.
René M GießCharité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health NeuroCure Cluster of Excellence NeuroCure Clinical Research Center Berlin Germany.
Michael ScheelCharité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health NeuroCure Cluster of Excellence NeuroCure Clinical Research Center Berlin Germany.
Judith Bellmann-StroblCharité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health NeuroCure Cluster of Excellence NeuroCure Clinical Research Center Berlin Germany.
Jens WuerfelCharité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health NeuroCure Cluster of Excellence NeuroCure Clinical Research Center Berlin Germany.
Friedemann PaulCharité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health NeuroCure Cluster of Excellence NeuroCure Clinical Research Center Berlin Germany.
Tim SinneckerCharité - Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health NeuroCure Cluster of Excellence NeuroCure Clinical Research Center Berlin Germany.
Berlin Institute of Health at Charité - Universitätsmedizin Berlin · DEFreie Universität Berlin · DEHumboldt-Universität zu Berlin · DECharité - Universitätsmedizin Berlin · DEHeidelberg University · DEMax Delbrück Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBaló's concentric sclerosis (BCS) is a rare condition characterized by concentrically layered white matter lesions. While its pathogenesis is unknown, hypoxia-induced tissue injury and chemotactic stimuli have been proposed as potential causes of BCS lesion formation. BCS has been suggested to be a variant of multiple sclerosis (MS). Here, we aimed to elucidate similarities and differences between BCS and MS by describing lesion morphology and localization in high-resolution 7 Tesla (7 T) magnetic resonance imaging (MRI) scans.

methodsTen patients with Baló-type lesions underwent 7 T MRI, and 10 relapsing remitting MS patients served as controls. The 7 T MR imaging protocol included 3D T

resultsIntralesional veins were visible in the center of all but one Baló-type lesion. Four Baló-type lesions displayed inhomogeneous intralesional T

conclusionOur findings support the hypothesis that BCS and MS share common pathogenetic mechanisms but patients present with different lesion phenotypes.

Identifiers

PMID30128315
PMCPMC6093849
OpenAlexW2810944713

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.